In 2021, 529 million people were living with diabetes worldwide, and an estimated 1·31 billion individuals are projected to ...

The Danish drugmaker is expanding Wegovy access via telehealth providers like Hims and Ro. But the gap with Eli Lilly is only ...

Todd Engels, 62, from Maryland, started taking Ozempic after he saw glowing headlines and slick ads praising it as a 'miracle ...

Researchers in Dallas want to know if the class of drugs, GIP/GLP-1 receptor agonists, might be a secret weapon in the fight ...

Becky Davis of Charles River Associates predicts that an influx of new and oral GLP-1 drugs, along with pricing pressures ...

Asembia Specialty Pharmacy Summit, Becky Davis, principal at Charles River Associates, discussed how employer-based insurance ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...

You wanted a tighter waistline — and ended up with a looser face. As Ozempic and other GLP-1 weight-loss medications ...

There was a marked increased in the detection of illegal weight loss type medicines, as more than a million units of illegal ...

Aussie movie star Rebel Wilson has gotten candid about her new “health challenge” after having a “moment of weakness” with ...

Aon’s analysis found that while GLP-1 weight loss drugs increased costs initially, they lead to a reduction in long-term medical expenses due to fewer health issues.

Novo Nordisk said that it will begin offering its popular weight loss drug Wegovy through telehealth companies Hims & Hers, Ro and LifeMD to expand patient access, now that the medication is no longer ...